When to Speak with Your GP About GLP-1 and Immunity Whilst GLP-1 receptor agonists are generally well-tolerated and do not compromise immune function, there are specific circumstances when patients should contact their GP or healthcare team for guidance and reassurance
Stay there
Angerbauer argues that preventive treatments for healthy adults should be held to a higher standard because healthy people have less to gain and more to lose from potential side effects, making it essential to demonstrate a clear and substantial net benefit
Additionally, the gastrointestinal side effects could be particularly distressing for individuals with heightened anxiety around bodily sensations or digestive symptoms
[52], [53] Further complicating this is the fact that many providers perceive NAFLD as a benign entity and subsequently, many patients with a high likelihood of NAFLD do not complete formal evaluation to confirm the diagnosis and are not subsequently referred to specialists who are involved in clinical trial recruitment.[54], [55] Primary care physicians, endocrinologists, gynaecologists, cardiologists and to some extent gastroenterologists lack awareness of NAFLD/NASH progression and its associated risk factors." Summary Non-alcoholic fatty liver disease (NAFLD) has become one of the most prominent forms of chronic liver disease worldwide, reflecting the epidemic of global obesity
